Latest News
New Brand Launched, LASFIT AIR Revolutionizes Air Inflation Technology with Airmaster Inflator
Inflating with Confidence, Journey without Worries. LASFIT AIR is taking the
innovation with Airmaster Inflator.
LOS ANGELES, Oct. 26, 2023 /PRNewswire/ -- On October 25th, 2023, LASFIT AIR
Positive results from first-in-human completely leadless CRT in the US, published in The Journal of the American College of Cardiology
SUNNYVALE, Calif., Oct. 25, 2023 /PRNewswire/ -- EBR Systems, Inc.
Monport Laser Unleashes a Hauntingly Good Halloween Event with New Products and Unbeatable Discounts
NEW YORK, Oct. 25, 2023 /PRNewswire/ -- Monport Laser, the leader of the laser
engraver
Neuragenex Brings Innovative Fibromyalgia Treatment to Patients Across the US
GULBERT, Ariz., Oct. 25, 2023 /PRNewswire/ -- Neuragenex, the national healthcare provider focused on non-pharmaceutical pain treatment, announced its continued expansion to bring relief to fibromyalgia patients across the country. With clinics now operating in Georgia, Texas, Illinois, Tenness...
Enfinity Global & ICG complete €400 million equity agreement
MIAMI, Oct. 25, 2023 /PRNewswire/ -- Enfinity Global, a leader in renewable energy, today announced the successful completion of €300 million equity funding from ICG, the global alternative asset manager. Another €100 million of equity funding is expected to close within a one-year period as part...
Qilu Pharmaceutical announces the latest results from its clinical study on QL1706, in combination with chemotherapy, as a first-line treatment for recurrent or metastatic cervical cancer
JINAN, China, Oct. 25, 2023 /PRNewswire/ -- On October 22, Qilu Pharmaceutical unveiled the latest findings from a multicenter, single-arm Phase II clinical trial at the European Society for Medical Oncology (ESMO) Annual Congress 2023. This trial studied the use of QL1706 (iparomlimab and tuvonr...
Qilu Pharmaceutical announces the latest results from its clinical study on QL1706, in combination with chemotherapy, as a first-line treatment for recurrent or metastatic cervical cancer
JINAN, China, Oct. 25, 2023 /PRNewswire/ -- On October 22, Qilu Pharmaceutical unveiled the latest findings from a multicenter, single-arm Phase II clinical trial at the European Society for Medical Oncology (ESMO) Annual Congress 2023. This trial studied the use of QL1706 (iparomlimab and tuvonr...
CCTV+: Enamored by Jiangxi - Lovely Flower
BEIJING, Oct. 25, 2023 /PRNewswire/ -- Cheng Linyao is an inheritor of the intangible heritage of Jingdezhen blue-and-white porcelain. In 2020, an iris in Istanbul inspired her and Haken, her Turkish husband. They brought the flower across the oceans to Jingdezhen and crafted Lovely Flower, a cera...
EaseUS Online Screen Recorder 2.0 Boosts Screen-Sharing Productivity on Windows, macOS, iPhone and Android Platforms
NEW YORK, Oct. 25, 2023 /PRNewswire/ -- EaseUS RecExperts is a free screen
recorder
Enfinity Global & ICG complete €400 million equity agreement
MIAMI, Oct. 25, 2023 /PRNewswire/ -- Enfinity Global, a leader in renewable energy, today announced the successful completion of €300 million equity funding from ICG, the global alternative asset manager. Another €100 million of equity funding is expected to close within a one-year period as part...
First Patient Dosed for MRCT Phase 3 Study on First-Line LS-SCLC of Henlius Anti-PD-1 mAb Serplulimab in Europe
SHANGHAI, Oct. 25, 2023 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the first patient inEurope has been dosed in the international multi-centre phase 3 clinical trial (NCT05353257) of the company's self-developed anti-PD-1 mAb HANSIZHUANG (serplulimab) in combination ...
Xailient and Morse Micro Join Forces to Transform the Future of Smart Cameras
Wi-Fi HaLow™ Technology Enables Long-Range, Low-Power Connectivity for Smart Cameras SYDNEY and IRVINE, Calif., Oct. 25, 2023 /PRNewswire/ -- Xailient, the leader in edge artificial intelligence (AI) for computer vision, today announced a strategic partnership with Morse Micro, a fast-growing fa...
Neo4j Enhances Cloud Database Performance Enabling up to 100X Faster Analytics and Real-Time Decision Making
Additional capabilities advance Neo4j's position as the authoritative data source for analytical and operational systems within an enterprise SAN MATEO, Calif., Oct. 25, 2023 /PRNewswire/ -- Neo4j®, the world's leading graph database and analytics company, announced major new capabilities enablin...
Agora Makes Livestream Shopping Technology Widely Available
Agora's live commerce capabilities help retail brands and platforms like CommentSold interact with customers in new ways SANTA CLARA, Calif., Oct. 25, 2023 /PRNewswire/ -- Agora, Inc. (NASDAQ: API), a pioneer and leading platform for real-time engagement APIs, has announced the wide availability...
EcoFlow Launches "Power for All" Initiative To Empower Communities During Times of Crisis
Product donations provide access to power during natural disasters in Hawaii, Morocco and more SEATTLE, Oct. 25, 2023 /PRNewswire/ -- EcoFlow, a pioneering portable power and eco-friendly energy solutions company, launched its "Power for All" initiative as part of the company's commitment to mak...
4 out of 12 Cybersecurity Leaders Shine in Latest Endpoint Prevention and Response Test by AV-Comparatives
- Here the EPR, EPP, XDR and EDR products to choose from for protecting digital assets and fighting against cybercrime. - The independent ISO-certified IT security test lab, AV-Comparatives, awards Check Point, ESET, Kaspersky, and Palo Alto Networks for their outstanding products in its latest ...
Trip.Biz Sets New Milestones in Global Business Travel at Global Partner Conference
Empowering Intelligent and Efficient Business Travel through Innovation and Collaboration SINGAPORE, Oct. 25, 2023 /PRNewswire/ -- Trip.com Group's Global Partner Summit and Trip.Biz Partner Conference, held onOctober 24, 2023, marked a significant milestone in the company's pursuit of globaliza...
FDA Meeting Feedback Puts Turn Biotechnologies on Track to be First Longevity Company Taking Cell Rejuvenation Therapy to Clinic
* FDA INTERACT meeting reviews Turn Bio's ERA™ and eTurna™ technologies, approach and plans, paving way toward its IND * Company continues to pace industry's cell regeneration therapy progress MOUNTAIN VIEW, Calif., Oct. 25, 2023 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation compa...
AALCO Continue to Voice the Interests of Asian-African Countries at Global Level
BALI, Indonesia, Oct. 25, 2023 /PRNewswire/ -- Indonesia will continue to encourage Asian-African Legal Consultative Organization (AALCO) to be the organization to voice the interests of Asian and African countries in the international level. A series of discussions as part of the 61st Annual Ses...
Hinen Ignites All-Energy Australia Exhibition with Cutting-Edge Energy Solutions
MELBOURNE, Australia, Oct. 25, 2023 /PRNewswire/ -- Hinen, a subsidiary of CE-LINK, unveiled a spectacular range of energy solutions at the All-Energy Australia Exhibition. Hinen's new product matrix promises to redefine the energy landscape with an array of products catering to the evolving need...
Week's Top Stories
Most Reposted
BoomerangFX Launches ChatGPT AI Search Advertising for Aesthetic, Wellness and Private-Pay Healthcare Practices, Powered by AUVIA™ AI Clinic Co-Pilot
[Picked up by 1316 media titles]
2026-11-17 23:03Manulife announces Subordinated Debenture issue
[Picked up by 1206 media titles]
2026-11-17 06:45The NYSE Welcomes vVARDIS as a Publicly Listed Company
[Picked up by 1176 media titles]
2026-11-14 13:23Sunbit to Enter Personal Loans in 2027 Along Its Growth Journey: NYSE Content Update
[Picked up by 1118 media titles]
2026-11-18 21:55Cision MCP Brings Consumer Intelligence into Everyday Workflows
[Picked up by 1116 media titles]
2026-11-19 23:00